Balanced news tone
News Sentiment
0775 sentiment intelligence
CK Life Sciences Int'l., (Holdings) Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-1.7% over one week, -13.2% over four weeks, trend inactive, and near fair-value range.
CK Life Sciences’ Sequencio Therapeutics Appoints Emily Tan as Chief Operating Officer
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
CK Life Sciences’ Sequencio Therapeutics Appoints Emily Tan as Chief Operating Officer
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2026 07:00
- Source
- Media OutReach Newswire
CK Life Sciences’ Sequencio Therapeutics Presents the Latest Vaccine Research Advancements at the American Association for Cancer Research Annual Meeting
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Apr 2026 07:00
- Source
- The Manila Times
CK Life Sciences sees low geopolitical risks in a US merger
- Tone
- Negative 34/100
- Event
- Deals and strategy
- Published
- 09 Oct 2025 07:00
- Source
- The Standard (HK)
TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiary of CK Life Sciences to form a first-in-class unique immuno-oncology and metastatic prevention oncology company
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 08 Oct 2025 07:00
- Source
- PR Newswire
TransCode Therapeutics To Acquire Polynoma; $25M Financing By a Subsidiary Of CK Life Sciences
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Oct 2025 07:00
- Source
- citybiz
CK Life Sciences' unit to merge with Nasdaq-listed TransCode Therapeutics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Aug 2025 07:00
- Source
- The Standard (HK)
Unit Of Li Ka-Shing’s CK Life Sciences To Merge With Nasdaq-Listed Biotech Company In $100 Million Deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 08 Oct 2024 07:00
- Source
- Forbes
XtalPi and CK Life Sciences Ink Agreement to Develop Cancer Molecular Diagnostic Models using AI and Biomarker Data
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Nov 2023 08:00
- Source
- PR Newswire
CK Life Sciences Presenting Preclinical Data for Its Investigational Dual-Antigen Cancer Vaccines, Co-targeting PRAME and PD-L1, at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting #CKLifeSciences #CancerVaccines #R&D
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 01 Nov 2023 07:00
- Source
- Media OutReach Newswire
XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development, opening a new paradigm for scientific innovation
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Nov 2022 08:00
- Source
- PR Newswire
Stocks Blog: CK Life Sciences plunges; 6 companies debut in Hong Kong -- the most on one day in 2019
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Nov 2019 08:00
- Source
- South China Morning Post